calendar
4,349 catalysts · 4,301 phase readout · 2,248 8k filing · 282 earnings · 172 phase 2 completion · 93 drug shortage · 73 phase 1 completion
next 91 dayslessmore
MonWedFri
4,349 catalysts · 4,301 phase readout · 2,248 8k filing · 282 earnings · 172 phase 2 completion · 93 drug shortage · 73 phase 1 completion
Sponsor: Dr. Steven Brooks. Phase: NA. Conditions: Out-Of-Hospital Cardiac Arrest, Heart Arrest, Heart Diseases, Cardiovascular Diseases
Sponsor: University of Michigan Rogel Cancer Center. Phase: PHASE2. Conditions: Oropharynx Cancer, HPV-Related Carcinoma
Sponsor: NRG Oncology. Phase: PHASE1. Conditions: Advanced Esophageal Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8, Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8, Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Pathologic Stage II Esophageal Adenocarcinoma AJCC v8, Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8, Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8, Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8, Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8, Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8, Pathologic Stage III Esophageal Adenocarcinoma AJCC v8, Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8, Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8, Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8, Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8, Unresectable Gastroesophageal Junction Adenocarcinoma, Squamous Cell Carcinoma, Squamous Cell Cancer
Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Breast Cancer, Lobular Breast Carcinoma, Breast Carcinoma, Metastatic Breast Cancer, Metastatic Lobular Breast Carcinoma, Metastatic Breast Carcinoma
Sponsor: AstraZeneca. Phase: PHASE2. Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Sponsor: Lakefront Biotherapeutics NV. Phase: PHASE2. Conditions: Systemic Lupus Erythematosus
Sponsor: AbbVie. Phase: PHASE3. Conditions: Myelodysplastic Syndrome (MDS)
Sponsor: Grünenthal GmbH. Phase: PHASE1. Conditions: Duchenne Muscular Dystrophy (DMD)
Sponsor: University of Southern California. Phase: PHASE1. Conditions: Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma, Advanced Malignant Solid Neoplasm, Metastatic Malignant Neoplasm in the Liver, Refractory Malignant Solid Neoplasm, Stage III Hepatocellular Carcinoma AJCC v8, Stage IV Hepatocellular Carcinoma AJCC v8
Sponsor: Shanghai Henlius Biotech. Phase: PHASE1. Conditions: Esophageal and/or Cardia Cancer, Melanoma, Urothelial Carcinoma (UC)
Sponsor: argenx. Phase: . Conditions: Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP, CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)
Sponsor: University of Nove de Julho. Phase: NA. Conditions: Insuficiência Cardíaca, Transplante Cardíaco, Exercício Físico
Sponsor: University of California, San Francisco. Phase: . Conditions: Copd, Smoking, Tobacco Use
Sponsor: National Cancer Centre, Singapore. Phase: . Conditions: Genetic Counselling
Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: Stroke
Sponsor: Shanghai University of Sport. Phase: NA. Conditions: Postural Stability, Motor Control, Sports Performance
Sponsor: Hawler Medical University. Phase: NA. Conditions: Preoperative Patient Education , Quality of Life , Cholecystectomy
Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation. Phase: PHASE2. Conditions: Pulmonary Arterial Hypertension
Sponsor: Emobot. Phase: NA. Conditions: Major Depressive Disorder (MDD)
Sponsor: Oregon Research Behavioral Intervention Strategies, Inc.. Phase: NA. Conditions: Grief, Post Traumatic Stress Disorder, Suicidal Ideation, Miscarriage, Stillbirth, Infant Death
Sponsor: Universidad Autonoma de Nuevo Leon. Phase: PHASE2. Conditions: Diabetic Foot Ulcer
Sponsor: Chongqing Peg-Bio Biopharm Co., Ltd.. Phase: PHASE1. Conditions: Thrombocytopenia Associated With Chronic Liver Disease
Sponsor: Busra Ercan. Phase: NA. Conditions: Intraoperative Complications
Sponsor: The Third Affiliated hospital of Zhejiang Chinese Medical University. Phase: NA. Conditions: Sarcopenia
Sponsor: Major Extremity Trauma Research Consortium. Phase: NA. Conditions: Post Operative Surgical Site Infection
Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: HR-HPV Testing
Sponsor: University of Rochester. Phase: PHASE3. Conditions: Lymphoma, Malignant Solid Neoplasm
Sponsor: Baylor Research Institute. Phase: NA. Conditions: Head and Neck Cancer
Sponsor: Northwestern University. Phase: NA. Conditions: Stone, Kidney
Sponsor: University of Copenhagen. Phase: NA. Conditions: Blood Flow
Sponsor: Francisco Garcia Torres. Phase: NA. Conditions: Cancer
Sponsor: Shandong Cancer Hospital and Institute. Phase: NA. Conditions: Soft Tissue Sarcoma (STS)
Sponsor: Spanish Oncology Genito-Urinary Group. Phase: . Conditions: Genitourinary Cancers
Sponsor: University of Nottingham. Phase: . Conditions: Falls, Vision; Disorder, Loss
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre. Phase: NA. Conditions: Peanut Allergy, Milk Allergy, Cow's, Egg Allergy
Sponsor: Abbott Medical Devices. Phase: NA. Conditions: Heart Failure, Ventricular Arrythmia
Sponsor: [Redacted]. Phase: . Conditions:
Sponsor: National Taiwan University Hospital. Phase: . Conditions: Oral Cancer
Sponsor: Compremium AG. Phase: NA. Conditions: Intracranial Pressure
Sponsor: AstraZeneca. Phase: PHASE3. Conditions: Breast Cancer
Sponsor: University of Oklahoma. Phase: PHASE1. Conditions: Urothelial Carcinoma
Sponsor: IRCCS San Raffaele. Phase: . Conditions: Acute Coronary Syndrome, Gender, Genetic Predisposition
Sponsor: Johns Hopkins University. Phase: . Conditions: Ischemic Stroke, Hypertension, Hyperlipidemias, Diabetes
Sponsor: Stephen Freedland. Phase: PHASE2. Conditions: Prostate Adenocarcinoma
Sponsor: Peking Union Medical College Hospital. Phase: PHASE2. Conditions: Hypoparathyroidism
Sponsor: Nova Scotia Health Authority. Phase: NA. Conditions: Breast Cancer Survivor, Colorectal Cancer Survivors
Sponsor: VA Office of Research and Development. Phase: EARLY_PHASE1. Conditions: Stroke
Sponsor: Stockholm University. Phase: NA. Conditions: Anxiety Disorders, Depression
Sponsor: TRiCares. Phase: NA. Conditions: Tricuspid Regurgitation (TR)
Sponsor: San Luigi Gonzaga Hospital. Phase: . Conditions: Coronary Artery Disease (CAD), Chronic Total Occlusion (CTO), Percutaneous Coronary Intervention (PCI), Optimal Medical Therapy